Cargando…
An annotated corpus with nanomedicine and pharmacokinetic parameters
A vast amount of data on nanomedicines is being generated and published, and natural language processing (NLP) approaches can automate the extraction of unstructured text-based data. Annotated corpora are a key resource for NLP and information extraction methods which employ machine learning. Althou...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644562/ https://www.ncbi.nlm.nih.gov/pubmed/29066897 http://dx.doi.org/10.2147/IJN.S137117 |
_version_ | 1783271748519591936 |
---|---|
author | Lewinski, Nastassja A Jimenez, Ivan McInnes, Bridget T |
author_facet | Lewinski, Nastassja A Jimenez, Ivan McInnes, Bridget T |
author_sort | Lewinski, Nastassja A |
collection | PubMed |
description | A vast amount of data on nanomedicines is being generated and published, and natural language processing (NLP) approaches can automate the extraction of unstructured text-based data. Annotated corpora are a key resource for NLP and information extraction methods which employ machine learning. Although corpora are available for pharmaceuticals, resources for nanomedicines and nanotechnology are still limited. To foster nanotechnology text mining (NanoNLP) efforts, we have constructed a corpus of annotated drug product inserts taken from the US Food and Drug Administration’s Drugs@FDA online database. In this work, we present the development of the Engineered Nanomedicine Database corpus to support the evaluation of nanomedicine entity extraction. The data were manually annotated for 21 entity mentions consisting of nanomedicine physicochemical characterization, exposure, and biologic response information of 41 Food and Drug Administration-approved nanomedicines. We evaluate the reliability of the manual annotations and demonstrate the use of the corpus by evaluating two state-of-the-art named entity extraction systems, OpenNLP and Stanford NER. The annotated corpus is available open source and, based on these results, guidelines and suggestions for future development of additional nanomedicine corpora are provided. |
format | Online Article Text |
id | pubmed-5644562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56445622017-10-24 An annotated corpus with nanomedicine and pharmacokinetic parameters Lewinski, Nastassja A Jimenez, Ivan McInnes, Bridget T Int J Nanomedicine Original Research A vast amount of data on nanomedicines is being generated and published, and natural language processing (NLP) approaches can automate the extraction of unstructured text-based data. Annotated corpora are a key resource for NLP and information extraction methods which employ machine learning. Although corpora are available for pharmaceuticals, resources for nanomedicines and nanotechnology are still limited. To foster nanotechnology text mining (NanoNLP) efforts, we have constructed a corpus of annotated drug product inserts taken from the US Food and Drug Administration’s Drugs@FDA online database. In this work, we present the development of the Engineered Nanomedicine Database corpus to support the evaluation of nanomedicine entity extraction. The data were manually annotated for 21 entity mentions consisting of nanomedicine physicochemical characterization, exposure, and biologic response information of 41 Food and Drug Administration-approved nanomedicines. We evaluate the reliability of the manual annotations and demonstrate the use of the corpus by evaluating two state-of-the-art named entity extraction systems, OpenNLP and Stanford NER. The annotated corpus is available open source and, based on these results, guidelines and suggestions for future development of additional nanomedicine corpora are provided. Dove Medical Press 2017-10-12 /pmc/articles/PMC5644562/ /pubmed/29066897 http://dx.doi.org/10.2147/IJN.S137117 Text en © 2017 Lewinski et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Lewinski, Nastassja A Jimenez, Ivan McInnes, Bridget T An annotated corpus with nanomedicine and pharmacokinetic parameters |
title | An annotated corpus with nanomedicine and pharmacokinetic parameters |
title_full | An annotated corpus with nanomedicine and pharmacokinetic parameters |
title_fullStr | An annotated corpus with nanomedicine and pharmacokinetic parameters |
title_full_unstemmed | An annotated corpus with nanomedicine and pharmacokinetic parameters |
title_short | An annotated corpus with nanomedicine and pharmacokinetic parameters |
title_sort | annotated corpus with nanomedicine and pharmacokinetic parameters |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644562/ https://www.ncbi.nlm.nih.gov/pubmed/29066897 http://dx.doi.org/10.2147/IJN.S137117 |
work_keys_str_mv | AT lewinskinastassjaa anannotatedcorpuswithnanomedicineandpharmacokineticparameters AT jimenezivan anannotatedcorpuswithnanomedicineandpharmacokineticparameters AT mcinnesbridgett anannotatedcorpuswithnanomedicineandpharmacokineticparameters AT lewinskinastassjaa annotatedcorpuswithnanomedicineandpharmacokineticparameters AT jimenezivan annotatedcorpuswithnanomedicineandpharmacokineticparameters AT mcinnesbridgett annotatedcorpuswithnanomedicineandpharmacokineticparameters |